Both in Biotechnology
Anavex Life Sciences vs Armata Pharmaceuticals
Over the past year AVXL returned −85.1% and ARMP returned −33.2%; their daily moves had a correlation of 0.10.
AVXL −85.1% ARMP −33.2%Growth of $1, one year, split-adjusted
| Metric | AVXL | ARMP |
|---|---|---|
| Price | $1.19 | $3.28 |
| Market cap | $110.3M | $122.0M |
| Today | −8.46% | +0.92% |
| 1 month | −37.0% | −0.9% |
| 6 months | −64.2% | −63.1% |
| Year to date | −66.6% | −47.8% |
| 1 year | −85.2% | −39.9% |
| Revenue growth (YoY) | — | +15.7% |
| Gross margin | — | 100.0% |
| Net margin | — | 2953.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 22.0× |
| Net cash | $118.3M | -$259.6M |
| Dividend yield | — | — |
| Volatility (60d) | 73.1% | 111.1% |
| Short % of float | 14.0% | 4.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).